Towards Precise and Rapid Diagnosis of Heparin-Induced Thrombocytopenia: a Prospective, Multicentre Cohort Study (“TORADI-HIT”)
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Jacksonville, Florida: 18-004323
Sponsor Protocol Number: 18-004323
About this study
The purpose of this study is to develop and validate a clinical prediction rule for the diagnosis of HIT.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Anti-PF4/heparin antibody test requested, or
- Clinical assessment tool (4Ts score) applied
Exclusion Criteria:
- Age below 18 years, or
- General informed consent of the institution not provided, or
- No residual serum sample available, or
- No in-house patient
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Jacksonville, Fla.
Mayo Clinic principal investigator Prakash Vishnu, M.B.B.S. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available